A BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP of the European Pharmacopoeia monograph is often referred to as a BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea Certificate of Suitability (COS). The purpose of a BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea to their clients by showing that a BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP has been issued for it. The manufacturer submits a BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP (COS) as part of the market authorization procedure, and it takes on the role of a BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP holder for the record. Additionally, the data presented in the BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea DMF.
A BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of BCNU; 1,3-Bis(2-chloroethyl)-1-nitrosourea suppliers with CEP (COS) on PharmaCompass.